uniQure NV (LTS:0EE0) Valuation Rank


LTS:0EE0 uniQure NV LTS:0EE0
47 GF Score
Price $42.90
GF Value $5.79
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is uniQure NV Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

uniQure NV Valuation Rank Related Terms

LTS:0EE0
47GF Score
uniQure NV LTS:0EE0
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is uniQure NV (LTS:0EE0) Overvalued in 2026?

Based on GuruFocus' analysis, uniQure NV stock appears to be overvalued. The current stock price of $42.90 is trading 640.9% above its estimated GF Value™ of $5.79. GuruFocus considers uniQure NV to be Significantly Overvalued.

Key valuation signals for LTS:0EE0:

  • Valuation Rank:
  • GF Value™: $5.79 vs. price of $42.90 (640.9% above fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the LTS:0EE0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

uniQure NV Business Description

Address Paasheuvelweg 25, Amsterdam, NH, NLD, 1105 BP
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
47GF Score

Get the complete analysis for LTS:0EE0

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$42.90
Price
$5.79
GF Value